Initial immunochemical characterization of MX35 ovarian cancer antigen Journal Article


Authors: Welshinger, M.; Yin, B. W. T.; Lloyd, K. O.
Article Title: Initial immunochemical characterization of MX35 ovarian cancer antigen
Abstract: Monoclonal antibody (mAb) MX35 reacts with approximately 90% of ovarian epithelial cancers and has been studied in localization and biodistribution trials in ovarian cancer patients. This study shows that mAb MX35 recognizes a cell surface antigen of about 95,000 D on OVCAR-3 ovarian cancer cells. The antigen could be immunoprecipitated from lysates of cells metabolically labeled with [3H]glucosamine and it bound to concanavalin A and wheat germ agglutinin lectins, showing that it is a glycoprotein. MX35 antigen can also be detected in detergent lysates of OVCAR-3 cells by Western blotting. Using this technique the MX35 epitope(s) was shown to be heat stable but susceptible to reduction by 2-mercaptoethanol. Protease digestion of the antigen resulted in smaller fragments (42-52 kDa) that still reacted with antibody. We conclude that MX35 antigen is a 95 kDa glycoprotein, stabilized by disulfide bonds, with a large protease-resistant region that carries the MX35 epitopes.
Keywords: human cell; antigen expression; ovarian neoplasms; ovary cancer; tumor cells, cultured; tumor antigen; monoclonal antibody; antigens, neoplasm; immunoprecipitation; epithelium cell; receptor affinity; molecular weight; immunochemistry; cell lysate; cell surface; epitopes; disulfide bond; precipitin tests; humans; human; female; priority journal; article
Journal Title: Gynecologic Oncology
Volume: 67
Issue: 2
ISSN: 0090-8258
Publisher: Elsevier Inc.  
Date Published: 1997-11-01
Start Page: 188
End Page: 192
Language: English
DOI: 10.1006/gyno.1997.4846
PUBMED: 9367706
PROVIDER: scopus
DOI/URL:
Notes: Article -- Export Date: 17 March 2017 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Beatrice Yin
    25 Yin
  2. Kenneth O Lloyd
    163 Lloyd